Skip to main content

Table 2 Comparisons between QLQ-C30 versions—univariable analyses (unadjusted)

From: Investigating the response scale of the EORTC QLQ-C30 in German cancer patients and a population survey

 

Cancer patients between-group comparisons

N = 450a

Cancer patients within-group comparisons

N = 229b

German population between-group comparisons

N = 2033

 

mäßig version

(n = 226)

ziemlich version

(n = 224)

 

mäßig version

(n = 229)

ziemlich version

(n = 229)

 

mäßig version

(n = 1006)

ziemlich version

(n = 1027)

 
 

m

sd

m

sd

p

m

sd

m

sd

p

m

sd

m

sd

p

PF

70.5

26.5

69.5

25.0

0.674

73.3

25.3

77.3

21.5

< 0.001

82.0

21.5

84.2

19.7

0.019

RF

62.0

35.1

62.8

34.5

0.813

64.5

31.6

68.4

30.3

0.007

80.3

27.4

82.4

25.2

0.067

EF

61.0

27.5

67.4

23.6

0.008

68.9

24.7

71.6

22.5

0.008

75.1

24.2

76.1

23.0

0.318

CF

76.5

26.3

80.7

22.8

0.072

81.9

23.7

83.1

20.3

0.194

85.4

21.1

86.6

18.9

0.163

SF

62.5

33.7

65.9

30.8

0.257

67.8

31.4

70.1

29.1

0.111

85.1

25.5

86.7

22.9

0.144

FA

44.4

29.7

41.8

29.3

0.356

36.9

28.1

34.8

25.9

0.064

31.4

27.7

29.1

24.8

0.050

NV

12.2

20.0

11.9

21.0

0.892

7.2

14.1

7.5

16.1

0.772

5.2

15.7

4.5

14.0

0.284

PA

30.0

31.9

28.9

30.6

0.716

26.6

30.1

24.3

27.6

0.062

28.3

31.1

26.2

28.0

0.101

DY

28.0

32.5

27.2

31.7

0.806

25.9

32.4

23.7

28.9

0.108

19.6

27.8

17.8

25.3

0.109

SL

41.0

36.4

32.1

32.2

0.006

32.9

34.9

28.5

29.8

0.005

28.9

33.6

27.9

31.1

0.525

AP

30.1

35.3

26.1

34.6

0.230

23.0

33.1

20.0

28.2

0.058

9.3

22.2

7.9

19.3

0.123

CO

17.3

29.3

16.4

28.5

0.764

13.4

24.5

12.7

24.8

0.560

8.9

21.6

8.0

19.8

0.296

DI

18.0

29.3

15.8

25.9

0.410

13.1

24.4

12.7

22.5

0.746

9.7

22.2

8.0

19.3

0.067

FI

22.8

31.1

20.5

28.0

0.414

20.7

30.6

18.7

26.7

0.140

10.4

24.1

9.2

22.4

0.238

Summary

70.1

19.9

73.0

18.6

0.116

75.1

18.3

77.4

16.8

< 0.001

82.0

17.7

83.6

15.9

0.038

  1. The EORTC QLQ-C30 was presented in two versions. The conventional version used mäßig and the optimized version used ziemlich as response option 3 of the 4-point Likert scale
  2. PF physical functioning, RF role functioning, EF emotional functioning, CF cognitive functioning, SF social functioning, FA fatigue, NV nausea and vomiting, PA pain, DY dyspnea, SL insomnia, AP appetite loss, CO constipation, DI diarrhea, FI financial difficulties
  3. aFor the between-group comparisons, QLQ-C30 data of cancer patients of the first assessment were compared
  4. bFor the within-group comparisons, cancer patients without changes in health and quality of life between both assessments were used